HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful use of alemtuzumab in a child with refractory peripheral T-cell posttransplant lymphoproliferative disorder.

AuthorsSandip Bartakke, Oussama Abla, Sheila Weitzman
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 30 Issue 10 Pg. 787-8 (Oct 2008) ISSN: 1536-3678 [Electronic] United States
PMID19011483 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Alemtuzumab
Topics
  • Alemtuzumab
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm (therapeutic use)
  • Female
  • Heart Transplantation (adverse effects)
  • Humans
  • Infant
  • Lymphoproliferative Disorders (drug therapy, etiology)
  • T-Lymphocytes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: